Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Koenecke, Christian ORCID: 0000-0001-7025-1735, Goehring, Gudrun, de Wreede, Liesbeth C., van Biezen, Anja, Scheid, Christof, Volin, Liisa ORCID: 0000-0002-9731-8335, Maertens, Johan, Finke, Juergen, Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Robin, Marie ORCID: 0000-0003-1388-9876, Passweg, Jakob, Cornelissen, Jan, Beelen, Dietrich ORCID: 0000-0001-5050-220X, Heuser, Michael ORCID: 0000-0001-5318-9044, de Witte, Theo and Kroeger, Nicolaus (2015). Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Haematologica, 100 (3). S. 400 - 409. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Koenecke, Christian ORCID: 0000-0001-7025-1735, Goehring, Gudrun, de Wreede, Liesbeth C., van Biezen, Anja, Scheid, Christof, Volin, Liisa ORCID: 0000-0002-9731-8335, Maertens, Johan, Finke, Juergen, Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Robin, Marie ORCID: 0000-0003-1388-9876, Passweg, Jakob, Cornelissen, Jan, Beelen, Dietrich ORCID: 0000-0001-5050-220X, Heuser, Michael ORCID: 0000-0001-5318-9044, de Witte, Theo and Kroeger, Nicolaus (2015). Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Haematologica, 100 (3). S. 400 - 409. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Kroeger, Nicolaus, Brand, Ronald, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Weber, Thomas, Robin, Marie, Stelljes, Matthias, Afanasiev, Boris V., Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Gramatzki, Martin, Bethge, Wolfgang A., Poire, Xavier, Kobbe, Guido, van Os, Marleen, Iacobelli, Simona and de Witte, Theo (2014). Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kroeger, Nicolaus, Iacobelli, Simona, Franke, Georg-Nikolaus, Platzbecker, Uwe, Uddin, Ruzena, Huebel, Kai, Scheid, Christof, Weber, Thomas, Robin, Marie ORCID: 0000-0003-1388-9876, Stelljes, Matthias, Afanasyev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco ORCID: 0000-0002-2991-3474, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa ORCID: 0000-0002-9731-8335, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Brand, Ronald and de Witte, Theo (2017). Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). J. Clin. Oncol., 35 (19). S. 2157 - 2167. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kroeger, Nicolaus, Iacobelli, Simona, Koster, Linda, Niederwieser, Dietger, Platzbecker, Uwe, Huebel, Kai, Scheid, Christoph, Weber, Thomas, Stelljes, Matthias, Afanasiev, Boris, Heim, Dominik, Deliliers, Giorgio Lambertenghi, Onida, Francesco, Dreger, Peter, Pini, Massimo, Guidi, Stefano, Volin, Liisa, Guenther, Andreas, Bethge, Wolfgang, Poire, Xavier, Kobbe, Guido, van Os, Marleen, Yakoub-Agha, Ibrahim and Robin, Marie (2018). Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri Mar 29 12:51:28 2024 CET.